Michaël V. Lukens

1.1k total citations
24 papers, 798 citations indexed

About

Michaël V. Lukens is a scholar working on Epidemiology, Hematology and Immunology. According to data from OpenAlex, Michaël V. Lukens has authored 24 papers receiving a total of 798 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 8 papers in Hematology and 8 papers in Immunology. Recurrent topics in Michaël V. Lukens's work include Respiratory viral infections research (9 papers), Immune Cell Function and Interaction (7 papers) and Neonatal Respiratory Health Research (4 papers). Michaël V. Lukens is often cited by papers focused on Respiratory viral infections research (9 papers), Immune Cell Function and Interaction (7 papers) and Neonatal Respiratory Health Research (4 papers). Michaël V. Lukens collaborates with scholars based in Netherlands, Germany and United Kingdom. Michaël V. Lukens's co-authors include Grada M. van Bleek, Jan L. L. Kimpen, Frank E. J. Coenjaerts, Caroline M. M. van Geelen, Ferenc A. Scheeren, Arjen Q. Bakker, Tim Beaumont, Andreas Radbruch, Sean A. Diehl and Etsuko Yasuda and has published in prestigious journals such as Nature Medicine, The Journal of Immunology and PLoS ONE.

In The Last Decade

Michaël V. Lukens

24 papers receiving 786 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michaël V. Lukens Netherlands 12 472 312 220 193 78 24 798
Isabel Caragol Spain 14 193 0.4× 386 1.2× 80 0.4× 193 1.0× 108 1.4× 34 696
Jennifer Canniff United States 13 231 0.5× 183 0.6× 226 1.0× 77 0.4× 84 1.1× 27 837
Huawei Mao China 17 495 1.0× 808 2.6× 62 0.3× 176 0.9× 132 1.7× 40 1.1k
Emil Miskovsky United States 15 427 0.9× 182 0.6× 71 0.3× 70 0.4× 135 1.7× 18 813
D M Ambrosino United States 15 330 0.7× 293 0.9× 78 0.4× 50 0.3× 62 0.8× 22 679
Darlene Charboneau United States 12 462 1.0× 209 0.7× 114 0.5× 51 0.3× 103 1.3× 15 772
Yoshihiro Furuichi Japan 13 693 1.5× 337 1.1× 80 0.4× 80 0.4× 57 0.7× 53 1.1k
Abdul W. Ansari United States 16 188 0.4× 368 1.2× 57 0.3× 148 0.8× 96 1.2× 38 712
M. Coşkun Türkiye 8 185 0.4× 288 0.9× 48 0.2× 138 0.7× 113 1.4× 9 557
Marie‐Pierre Ledoux France 12 333 0.7× 102 0.3× 72 0.3× 387 2.0× 62 0.8× 19 741

Countries citing papers authored by Michaël V. Lukens

Since Specialization
Citations

This map shows the geographic impact of Michaël V. Lukens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michaël V. Lukens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michaël V. Lukens more than expected).

Fields of papers citing papers by Michaël V. Lukens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michaël V. Lukens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michaël V. Lukens. The network helps show where Michaël V. Lukens may publish in the future.

Co-authorship network of co-authors of Michaël V. Lukens

This figure shows the co-authorship network connecting the top 25 collaborators of Michaël V. Lukens. A scholar is included among the top collaborators of Michaël V. Lukens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michaël V. Lukens. Michaël V. Lukens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meijer, Karina, Karlijn J. van Stralen, Barbara Maat, et al.. (2024). Smaller nadroparin dose reductions required for patients with renal impairment: A multicenter cohort study. Thrombosis Research. 236. 4–13. 1 indexed citations
2.
Folman, Claudia C., et al.. (2024). Major reduction in occurrence of anti‐c and anti‐E in pregnancy after more than 10 years of preventive matched transfusion with most benefit for c‐matching. British Journal of Haematology. 205(4). 1599–1604. 3 indexed citations
3.
Lukens, Michaël V., et al.. (2023). Occurrence of FVIII Inhibitors in Hemophilia A Patients Following an Institutional Switch to a Third Generation B-Domain-Deleted FVIII. Clinical and Applied Thrombosis/Hemostasis. 29. 2995348920–2995348920. 1 indexed citations
4.
Vleming, Louis Jean, Casper Franssen, Jeroen Diepstraten, et al.. (2022). Optimising the Nadroparin Dose for Thromboprophylaxis During Hemodialysis by Developing a Population Pharmacodynamic Model Using Anti-Xa Levels. Clinical Pharmacokinetics. 61(11). 1559–1569. 1 indexed citations
5.
Svendsen, Arthur Flohr, Martijn van Faassen, Niels Kloosterhuis, et al.. (2021). Hepatocyte-specific glucose-6-phosphatase deficiency disturbs platelet aggregation and decreases blood monocytes upon fasting-induced hypoglycemia. Molecular Metabolism. 53. 101265–101265. 7 indexed citations
6.
Meijer, Piet, et al.. (2021). Impact of COVID‐19 pandemic on the quality of test output in haemostasis laboratories. International Journal of Laboratory Hematology. 44(2). 407–413. 3 indexed citations
7.
Folman, Claudia C., Michaël V. Lukens, Peter C. Ligthart, et al.. (2021). Reduction of anti‐K‐mediated hemolytic disease of newborns after the introduction of a matched transfusion policy: A nation‐wide policy change evaluation study in the Netherlands. Transfusion. 61(3). 713–721. 17 indexed citations
8.
Lukens, Michaël V., Joyce Curvers, Caroline Roozendaal, et al.. (2020). Comparison of different immunoassays for the detection of antibodies against Intrinsic Factor and Parietal Cells. Journal of Immunological Methods. 487. 112867–112867. 7 indexed citations
9.
Mulder, René, Karina Meijer, & Michaël V. Lukens. (2020). Genetic testing of hereditary antithrombin deficiency in a large US pedigree using saliva samples. International Journal of Laboratory Hematology. 43(3). e101–e103. 2 indexed citations
10.
Croles, F. Nanne, Michaël V. Lukens, René Mulder, et al.. (2019). Monitoring of heparins in antithrombin-deficient patients. Thrombosis Research. 175. 8–12. 23 indexed citations
11.
Mulder, René, et al.. (2018). High protein S activity due to C4b‐binding protein deficiency in a 34‐year‐old Surinamese female with ischemic retinopathy. Clinical Case Reports. 6(5). 935–938. 5 indexed citations
12.
Croles, F. Nanne, René Mulder, André B. Mulder, Michaël V. Lukens, & Karina Meijer. (2018). β-Antithrombin, subtype of antithrombin deficiency and the risk of venous thromboembolism in hereditary antithrombin deficiency: A family cohort study. Thrombosis Research. 168. 47–52. 2 indexed citations
13.
Mulder, René, F. Nanne Croles, André B. Mulder, et al.. (2017). SERPINC1 gene mutations in antithrombin deficiency. British Journal of Haematology. 178(2). 279–285. 29 indexed citations
14.
Schijf, Marcel A., Michaël V. Lukens, N. van Uden, et al.. (2013). Respiratory Syncytial Virus Induced Type I IFN Production by pDC Is Regulated by RSV-Infected Airway Epithelial Cells, RSV-Exposed Monocytes and Virus Specific Antibodies. PLoS ONE. 8(11). e81695–e81695. 42 indexed citations
15.
Schijf, Marcel A., Michaël V. Lukens, N. van Uden, et al.. (2011). Local innate and adaptive immune responses regulate inflammatory cell influx into the lungs after vaccination with formalin inactivated RSV. Vaccine. 29(15). 2730–2741. 22 indexed citations
16.
Kwakkenbos, Mark J., Sean A. Diehl, Etsuko Yasuda, et al.. (2009). Generation of stable monoclonal antibody–producing B cell receptor–positive human memory B cells by genetic programming. Nature Medicine. 16(1). 123–128. 220 indexed citations
17.
Heidema, Jojanneke, John W. A. Rossen, Michaël V. Lukens, et al.. (2008). Dynamics of Human Respiratory Virus-Specific CD8+ T Cell Responses in Blood and Airways during Episodes of Common Cold. The Journal of Immunology. 181(8). 5551–5559. 37 indexed citations
18.
Heidema, Jojanneke, Michaël V. Lukens, Wendy W. C. van Maren, et al.. (2007). CD8+ T Cell Responses in Bronchoalveolar Lavage Fluid and Peripheral Blood Mononuclear Cells of Infants with Severe Primary Respiratory Syncytial Virus Infections. The Journal of Immunology. 179(12). 8410–8417. 94 indexed citations
19.
Lukens, Michaël V., E Claassen, Mariska E. A. van Dijk, et al.. (2006). Characterization of the CD8+ T cell responses directed against respiratory syncytial virus during primary and secondary infection in C57BL/6 mice. Virology. 352(1). 157–168. 48 indexed citations
20.
Heidema, Jojanneke, Martien C. M. Poelen, Mariska E. A. van Dijk, et al.. (2004). HLA-DP4 presents an immunodominant peptide from the RSV G protein to CD4 T cells. Virology. 326(2). 220–230. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026